Literature DB >> 652514

[Progressive myoclonic encephalopathy in dialysis patients. The role of the water used for haemodialysis (author's transl)].

F Cartier, P Allain, J Gary, M Chatel, F Menault, S Pecker.   

Abstract

The observation in 14 dialysis patients of an encephalopathy associating myoclonia, dysarthria, generalised seizures in some cases, worsening over a few months, led to an aetiological inquiry based upon comparative study of patients with or without encephalopathy treated in the same centre or at home, and controls. Higher levels of aluminium were found in the frontal cortex grey matter of encephalopathy patients as compared to the control group. The same applies to manganese in the white matter. Copper, zinc and iron contents were not different. Aluminium levels in blood, dialysis bath and tap water supply were higher in center dialysis than in home dialysis. Blood aluminium levels at the end of hemodialysis were correlated with bath aluminium levels. The ingestion of alumine gels was not greater in the encephalopathy patients than in other hemodialysis patients; its estimation, in each case, was not related to the blood aluminium levels at the begining of hemodialysis. These finding indicate the need of a routine measure of metal content - mainly aluminium and manganese - in tap water used for dialysis, in order to treat this water if necessary.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 652514

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  5 in total

1.  Aluminum and the pathogenesis of dialysis dementia.

Authors:  A I Arieff
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Multiorgan aluminium deposits in a chronic haemodialysis patient. Electron microscope and microprobe studies.

Authors:  A Roth; C Nogues; P Galle; T Drüeke
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1984

3.  Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.

Authors:  I S Parkinson; M K Ward; D N Kerr
Journal:  J Clin Pathol       Date:  1981-11       Impact factor: 3.411

4.  Dialysis encephalopathy: recovery after interruption of aluminium intake.

Authors:  M Poisson; R Mashaly; B Lebkiri
Journal:  Br Med J       Date:  1978-12-09

5.  Plasma and urine aluminium concentrations in healthy subjects after administration of sucralfate.

Authors:  P Allain; Y Mauras; N Krari; J Duchier; A Cournot; J Larcheveque
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.